26 June 2002
Cracking the cancer code
Cracking the cancer code
Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it
Biotech Blog
Cracking the cancer code
Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it
Yali Friedman lives in Washington, DC and is author of Building Biotechnology. He is also founder of DrugPatentWatch.com, and has a long history in biotechnology media. read more…
